Standout Papers
- The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP (2006)
- Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia (2005)
Immediate Impact
3 by Nobel laureates 19 from Science/Nature 66 standout
Citing Papers
A timeline of tumour-associated macrophage biology
2023 Standout
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
Works of Richard Klasa being referenced
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
2009
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Richard Klasa | 5680 | 3964 | 2344 | 104 | 7.3k | |
| Réda Bouabdallah | 5579 | 4225 | 2301 | 124 | 8.0k | |
| Félix Reyes | 5367 | 3641 | 2067 | 55 | 7.3k | |
| Marco Ladetto | 4137 | 2884 | 1648 | 170 | 7.0k | |
| Carol S. Portlock | 4095 | 2639 | 1441 | 119 | 5.5k | |
| Fredrick B. Hagemeister | 6073 | 4291 | 2653 | 256 | 8.3k | |
| Bruce D. Cheson | 5264 | 3716 | 2950 | 126 | 9.5k | |
| Éric Van Den Neste | 5335 | 4120 | 1918 | 45 | 7.0k | |
| Marek Trněný | 4806 | 3916 | 2278 | 321 | 6.7k | |
| Jorge Romaguera | 7051 | 5289 | 3220 | 280 | 9.7k | |
| Lorenz Trümper | 3812 | 3200 | 2007 | 197 | 7.3k |
All Works
Loading papers...